EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review)

Shuo Li, Quan Ma, Keying Lian, Zhisheng Jiang, Yun Ma

Oncology Reports · 02.04.2026 · 55 (6) · 1-11

DOI: 10.3892/or.2026.9112 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 02.04.2026. Verfasst von Shuo Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Molecular Biology, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, P.R. China. Hauptthemen laut MEDLINE: Mi-2 Nucleosome Remodeling and Deacetylase Complex, DNA Damage, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mi-2 Nucleosome Remodeling and Deacetylase ComplexDNA DamageDrug Resistance, NeoplasmNeoplasmsHumansDisease ProgressionDNA RepairGene Expression Regulation, NeoplasticChromatin Assembly and DisassemblyAnimals

Stichwörter der Autor:innen

DNA damage responsechromatin remodelingchromodomain helicase DNA‑binding protein 4non‑coding RNAnucleosome remodeling and deacetylase complextreatment resistancetumor progression

Substanzen

Mi-2 Nucleosome Remodeling and Deacetylase ComplexCHD4 protein, human

Autor:innen und Institutionen

  • Institute of Biochemistry and Molecular Biology, Hengyang Medical College, University of South China, Hengyang, Hunan 421001, P.R. China.
  • Nuclear Power Institute of China, Chengdu, Sichuan 610213, P.R. China.
  • Department of Biochemistry and Molecular Biology, Laboratory of Nuclear Radiation DNA Damage and Repair, School of Basic Medicine, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China.

Zitieren

APA

Li, S., Ma, Q., Lian, K., Jiang, Z., & Ma, Y. (2026). Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review). Oncology Reports, 55(6), 1-11. https://doi.org/10.3892/or.2026.9112

Vancouver

Li S, Ma Q, Lian K, Jiang Z, Ma Y. Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review). Oncology Reports. 2026;55(6):1-11. doi:10.3892/or.2026.9112

BibTeX
@article{Li2026,
  author = {Li, Shuo and Ma, Quan and Lian, Keying and Jiang, Zhisheng and Ma, Yun},
  title = {Role of CHD4 in tumor progression, DNA damage response and treatment resistance (Review)},
  journal = {Oncology Reports},
  year = {2026},
  volume = {55},
  number = {6},
  pages = {1--11},
  doi = {10.3892/or.2026.9112}
}
Kostenlos starten →